Design and created by Guideline Central in participation with the American Academy of Pediatrics.
American Academy of Pediatrics
Publication Date: Aug 19, 2025
Page Last Updated: Jul 8, 2026
American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents: Policy Statement. Pediatrics. 2025; doi: 10.1542/peds.2025-073924
This policy statement updates the recommendations of the American Academy of Pediatrics (AAP) for the use of coronavirus disease 2019 (COVID-19) vaccines in the prevention of severe COVID-19 in children. These COVID-19 vaccine recommendations may change in future seasons or as additional variants emerge. These recommendations for the use of 2025-2026 COVID-19 vaccine are contingent upon the approval by the US Food and Drug Administration of updated COVID-19 vaccine products. COVID-19 continues to be a cause of hospitalization and death in the pediatric population. COVID-19 vaccines are safe and effective in protecting individuals and populations against serious outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, including post-acute sequelae of SARS-CoV-2 infection (PASC) and multisystem inflammatory syndrome in children (MIS-C).
D000086382 - COVID-19
D000086663 - COVID-19 Vaccines
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.